Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Biofortuna Expands Immunoassay Services | Contract Pharma

What are you searching for?

Sign in
Breaking News

Biofortuna Expands Immunoassay Services

Invests in production capabilities for immunoassay design, development and manufacture

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Biofortuna is expanding its IVD service portfolio to provide more focus on immunoassay design, development and manufacture. The company has invested in its production capabilities to include plate coating, washing, drying and quality control, as well as a manufacturing suite for immunoassay kits.
 
This expansion was driven by current customer projects and increasing demand from the market. These enhanced manufacturing capabilities expand existing immunoassay services and offers increased flexibility to clients.
  
This focus on immunoassay products will complement Biofortuna’s molecular IVD services, which include ISO 13485 accredited and FDA registered contract research, lyophilization, air-drying, manufacturing, dispensing and kitting of diagnostic products.
 
Biofortuna’s chief executive officer, Dr. Simon Douglas, said, “The success and growth of current projects has fueled the desire to increase our immunoassay offering. This expansion will allow for large scale manufacturing of ELISA-based kits to meet our customers’ growing needs.”
 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics